Provided by Tiger Fintech (Singapore) Pte. Ltd.

INNOVENT BIO

93.250
-1.800-1.89%
Volume:13.98M
Turnover:1.29B
Market Cap:159.74B
PE:-1.47K
High:94.150
Open:92.350
Low:90.600
Close:95.050
52wk High:109.100
52wk Low:28.650
Shares:1.71B
HK Float Shares:1.71B
Volume Ratio:0.82
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.063
ROE:8.43%
ROA:3.44%
PB:10.17
PE(LYR):-1,472.47
PS:12.84

Loading ...

JD Health Jumps Nearly 4% on Innovent Partnership; Brokers Foresee Strong H1 Results

Stock Track
·
Jul 15

HK Stock Alert: JD Health International Inc. Surges Nearly 4% on Strategic Alliance with Innovent Biologics; Major Brokers Predict Strong First-Half Earnings Beat

Stock Track
·
Jul 15

Innovent Biologics May See Stronger Commercial Outlook -- Market Talk

Dow Jones
·
Jul 08

Innovent Biologics Embarks on New Era of Global Innovation -- Market Talk

Dow Jones
·
Jul 08

Innovent Biologics Raises Nearly HK$4.3 Billion from Share Placement

MT Newswires Live
·
Jul 04

Innovent Biologics Completes HK$4.27 Billion Private Placement Under General Mandate

Reuters
·
Jul 04

LIVE MARKETS-Chinese biotech licensing deals draw U.S. interest despite modest size, Macquarie says

Reuters
·
Jul 04

HK Movers|HK Innovative Drug Concept Stocks Rose. Biostar Up 15%; Akeso Up 11%; SKB Bio And Innovent Bio Up More Than 7%

Tiger Newspress
·
Jul 03

Chinese Investors Dump Tencent, Xiaomi Shares as Rally Fizzles

Bloomberg
·
Jul 02

China's Innogen expects to complete weight-loss drug trials next year

Reuters
·
Jul 01

World's First Dual GCG/GLP-1 Receptor Agonist for Obesity Approved in China, Delivered via Ypsomed Autoinjector

Reuters
·
Jul 01

Innovent Biologics Announces New Share Options and Restricted Shares Plan for Employees

Reuters
·
Jun 30

Innovent Biologics's Weight-Loss Drug Could Start to Generate Revenue This Year -- Market Talk

Dow Jones
·
Jun 30

Innovent Biologics Inc. Highlights Dual Innovations at Oncology R&D Day, Pioneering Future Cancer Treatments

Reuters
·
Jun 30

China's medical products regulator approves Innovent Biologics's weight control injection

Reuters
·
Jun 27

Chinese Companies Line Up Nearly $2.0 Billion of Fundraising

Dow Jones
·
Jun 26

BRIEF-Innovent Biologics To Place 55 Million Placing Shares

Reuters
·
Jun 26

Innovent Biologics Inc. Conducted Annual General Meeting

Reuters
·
Jun 25

Innovent Biologics' Mazdutide NDA for Glycemic Control in T2D Under Review by China's NMPA

Reuters
·
Jun 24

Innovent Biologics Unveils Promising Preclinical Study Results for Novel Antibody-Peptide Conjugate Targeting Cardiovascular Risk Markers at ADA Conference

Reuters
·
Jun 22